⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for advanced or metastatic breast cancer

Every month we try and update this database with for advanced or metastatic breast cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of MRG002 in the Treatment of Patients With HER2-low Locally Advanced or Metastatic Breast Cancer (BC)NCT04742153
Advanced or Met...
MRG002
18 Years - Shanghai Miracogen Inc.
Pelareorep and Paclitaxel Injection in Chinese Patients With Advanced or Metastatic Breast CancerNCT05519059
Advanced or Met...
Pelareorep
18 Years - 70 YearsAdlai Nortye Biopharma Co., Ltd.
Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast CancerNCT01199367
Breast Cancer
KW-2450 in comb...
18 Years - Kyowa Kirin Co., Ltd.
Extended Treatment in Metastatic Breast Cancer With EribulinNCT02769364
Breast Cancer
18 Years - Eisai Inc.
A Phase I/II Clinical Trial of Vidaza With Abraxane in Patients With Advanced/Metastatic Solid Tumors and Breast CancerNCT00748553
Advanced or Met...
Advanced or Met...
Azacitidine (Vi...
Nab-paclitaxel ...
18 Years - University of Utah
Pelareorep and Paclitaxel Injection in Chinese Patients With Advanced or Metastatic Breast CancerNCT05519059
Advanced or Met...
Pelareorep
18 Years - 70 YearsAdlai Nortye Biopharma Co., Ltd.
Pelareorep and Paclitaxel Injection in Chinese Patients With Advanced or Metastatic Breast CancerNCT05519059
Advanced or Met...
Pelareorep
18 Years - 70 YearsAdlai Nortye Biopharma Co., Ltd.
Phase 1b Trial of Dinaciclib With Pembrolizumab for Advanced Breast CancerNCT01676753
Advanced or Met...
Triple Negative...
Dinaciclib
Pembrolizumab
18 Years - 85 YearsUniversity of California, San Francisco
Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer TumorsNCT00511576
Breast Cancer
Lung Cancer
Pulmonary Cance...
Non-Small-Cell ...
Prostate Cancer
Prostatic Cance...
Gastric Cancer
Stomach Cancer
MGCD0103 & Doce...
18 Years - Mirati Therapeutics Inc.
Milademetan and Fulvestrant in GATA3-mutant, ER+HER- Advanced or Metastatic Breast CancerNCT05932667
Advanced or Met...
Milademetan
Patient Reporte...
18 Years - Institut Curie
Extended Treatment in Metastatic Breast Cancer With EribulinNCT02769364
Breast Cancer
18 Years - Eisai Inc.
Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast CancerNCT01199367
Breast Cancer
KW-2450 in comb...
18 Years - Kyowa Kirin Co., Ltd.
Milademetan and Fulvestrant in GATA3-mutant, ER+HER- Advanced or Metastatic Breast CancerNCT05932667
Advanced or Met...
Milademetan
Patient Reporte...
18 Years - Institut Curie
Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast CancerNCT01199367
Breast Cancer
KW-2450 in comb...
18 Years - Kyowa Kirin Co., Ltd.
Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast CancerNCT04494425
Advanced or Met...
Trastuzumab der...
Capecitabine
Paclitaxel
Nab-Paclitaxel
18 Years - 105 YearsAstraZeneca
Implementing Patients´ Competence in Oral Breast Cancer TherapyNCT04030728
Metastatic Brea...
Advanced Breast...
18 Years - Onco Medical Consult GmbH
Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast CancerNCT04494425
Advanced or Met...
Trastuzumab der...
Capecitabine
Paclitaxel
Nab-Paclitaxel
18 Years - 105 YearsAstraZeneca
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: